| Authors: |
Evans DG; Genomic Medicine, University of Manchester - The Victoria University of Manchester Campus, Manchester, UK gareth.d.evans@manchester.ac.uk.; Genomic Diagnostic Laboratory, Manchester University NHS Foundation Trust, Manchester, UK., Morgan RD; Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.; cancer studies, University of Manchester, Manchester, UK., Forde C; Clinical Genetics Service, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK., Crosbie EJ; Division of Molecular and Clinical Cancer Sciences, The University of Manchester, Manchester, UK.; University of Manchester, Manchester, UK., Burghel GJ; Genomic Diagnostic Laboratory, Manchester University NHS Foundation Trust, Manchester, UK., Pugh S; Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK., Gandhi A; Prevent Breast Cancer Centre, Wythenshawe Hospital Manchester Universities Foundation Trust, Wythenshawe, UK., Howell A; Prevent Breast Cancer Centre, Manchester, UK., Howell SJ; Wythenshawe Hospital Manchester Universities Foundation Trust, Wythenshawe, UK.; The Christie NHS Foundation Trust, Manchester, UK., Woodward ER; Manchester Centre for Genomic Medicine, Central Manchester NHS Foundation Trust, Manchester, UK., Lalloo F; Clinical Genetics Service, Manchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK. |
